102 related articles for article (PubMed ID: 25330355)
1. Growth hormone enhances LNCaP prostate cancer cell motility.
Nakonechnaya AO; Shewchuk BM
Endocr Res; 2015; 40(2):97-105. PubMed ID: 25330355
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of exogenous and autocrine growth hormone on LNCaP prostate cancer cell proliferation and survival.
Nakonechnaya AO; Jefferson HS; Chen X; Shewchuk BM
J Cell Biochem; 2013 Jun; 114(6):1322-35. PubMed ID: 23238889
[TBL] [Abstract][Full Text] [Related]
3. Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma.
Brunet-Dunand SE; Vouyovitch C; Araneda S; Pandey V; Vidal LJ; Print C; Mertani HC; Lobie PE; Perry JK
Endocrinology; 2009 Mar; 150(3):1341-52. PubMed ID: 18974274
[TBL] [Abstract][Full Text] [Related]
4. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of HepaCAM inhibits cell viability and motility through suppressing nucleus translocation of androgen receptor and ERK signaling in prostate cancer.
Song X; Wang Y; Du H; Fan Y; Yang X; Wang X; Wu X; Luo C
Prostate; 2014 Jul; 74(10):1023-33. PubMed ID: 24811146
[TBL] [Abstract][Full Text] [Related]
7. Chronic hypoxia induces androgen-independent and invasive behavior in LNCaP human prostate cancer cells.
Yamasaki M; Nomura T; Sato F; Mimata H
Urol Oncol; 2013 Oct; 31(7):1124-31. PubMed ID: 22226664
[TBL] [Abstract][Full Text] [Related]
8. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
9. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
[TBL] [Abstract][Full Text] [Related]
10. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A
Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143
[TBL] [Abstract][Full Text] [Related]
11. Prosaptide TX14A stimulates growth, migration, and invasion and activates the Raf-MEK-ERK-RSK-Elk-1 signaling pathway in prostate cancer cells.
Koochekpour S; Sartor O; Lee TJ; Zieske A; Patten DY; Hiraiwa M; Sandhoff K; Remmel N; Minokadeh A
Prostate; 2004 Oct; 61(2):114-23. PubMed ID: 15305334
[TBL] [Abstract][Full Text] [Related]
12. Similarities and differences between effects of angiotensin III and angiotensin II on human prostate cancer cell migration and proliferation.
Domińska K; Piastowska-Ciesielska AW; Lachowicz-Ochędalska A; Ochędalski T
Peptides; 2012 Oct; 37(2):200-6. PubMed ID: 22884921
[TBL] [Abstract][Full Text] [Related]
13. Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility.
Massoner P; Colleselli D; Matscheski A; Pircher H; Geley S; Jansen Dürr P; Klocker H
Endocr Relat Cancer; 2009 Sep; 16(3):795-808. PubMed ID: 19509068
[TBL] [Abstract][Full Text] [Related]
14. Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.
Miles FL; Tung NS; Aguiar AA; Kurtoglu S; Sikes RA
Prostate; 2012 Sep; 72(12):1339-50. PubMed ID: 22228025
[TBL] [Abstract][Full Text] [Related]
15. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells.
Skvortsova I; Skvortsov S; Stasyk T; Raju U; Popper BA; Schiestl B; von Guggenberg E; Neher A; Bonn GK; Huber LA; Lukas P
Proteomics; 2008 Nov; 8(21):4521-33. PubMed ID: 18821526
[TBL] [Abstract][Full Text] [Related]
16. Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer.
Zhu Y; Wu J; Li S; Wang X; Liang Z; Xu X; Xu X; Hu Z; Lin Y; Chen H; Qin J; Mao Q; Xie L
Mol Med Rep; 2015 Feb; 11(2):1004-8. PubMed ID: 25351792
[TBL] [Abstract][Full Text] [Related]
17. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone.
Mukhina S; Mertani HC; Guo K; Lee KO; Gluckman PD; Lobie PE
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15166-71. PubMed ID: 15353581
[TBL] [Abstract][Full Text] [Related]
19. The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.
Hirai K; Nomura T; Yamasaki M; Inoue T; Narimatsu T; Chisato Nakada PD; Yoshiyuki Tsukamoto PD; Matsuura K; Sato F; Moriyama M; Mimata H
Urol Oncol; 2014 Feb; 32(2):101-9. PubMed ID: 23403204
[TBL] [Abstract][Full Text] [Related]
20. SRD5A2 gene expression inhibits cell migration and invasion in prostate cancer cell line via F-actin reorganization.
Aggarwal S; Singh M; Kumar A; Mukhopadhyay T
Mol Cell Biochem; 2015 Oct; 408(1-2):15-23. PubMed ID: 26092425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
